Intelligent drug delivery systems based on modified chitosan nanoparticles

Letters in Organic Chemistry

Volumn 9, Issue 1, 2012, Pages 56-70

  Saboktakin, Mohammad R ^a,b   Tabar, Neda A ^a   Tabatabaie, Roya M ^a   Maharramov, Abel ^b   Ramazanov, Mohammad A ^b  

^a International Research Institute of Arian Chemie Gostar   (Iran)

^b BAKU STATE UNIVERSITY   (Azerbaijan)

Author keywords

Drug delivery; Intelligent; Modified chitosan; Nanoparticles

Indexed keywords

EID: 84858978142     PISSN: 15701786     EISSN: None     Source Type: Journal    
DOI: 10.2174/157017812799303999     Document Type: Article

References (179)

1. Pathak, Y.; Thassu, D.; "Drug delivery nanoparticles formulations and characterization"; Informa Healthcare USA Inc., 2009, vol. 191.
2. Manish, P.; Patel, L.; Ravi, R.; Jayvadan, K.;"Chitosan Mediated Targeted Drug Delivery System"; J. Pharm. Pharmaceut. Sci.; 2010; 13(3) 536-557.
3. Reddy Putheti, R.; Okigbo, R.N.; Sai advanapu M.; Chavanpatil, S.; "Nanotechnology importance in the pharmaceutical industry"; African J. of Pure and App. Chem.; 2008; 2 (3), pp. 027-031.
4. Hein, S; W.K.; Stevens, W.F.; Kjems, J.; Chitosan composites for biomedical applications: status, challenges and perspectives. Mat. Sci. and Tech. 2008. 24: p. 1053-1061.
5. Schellekens, R.C.; A drawing behaviour of poly vinyl alcohol fibres. J. Appl. Polym. Sci. 1991. 43: p. 2311-2315.
6. Bigucci, F.; L.B.; Cerchiara, T.; Chitosan/pectin polyelectrolyte complexes: Selection of suitable preparative conditions for colonspecific delivery of vancomycin. Eur. J. Pharm. Sci. 2008. 35: p. 435-441.
7. Magnin, D.; L.J.; Chornet, E.; Dumitriu,, S.; Physicochemical and structural characterisation of a polyionic matrix of interest in biotechnology, in the pharmaceutical and biomedical fields. Carbohydr. Polymer. 2004. 55: p. 437-453.
8. Vasiliu, S.; Rinaudo, M.; Polyelectrolyte capsules made of two biocompatible natural polymers. Eur. Polym. J. 2004. 41: p. 923-932. (Pubitemid 40305021)
9. Naidu, V.G.M.; Sashidhar, R.B.; et al, Polyelectrolyte complexes of gum kondagogu and chitosan, as diclofenac carriers. Carbohydr. Polymer. 2009. 76: p. 464-471.
10. Foda, N.H.; Tadros, M.I.; Implantable biodegradable sponges: Effect of interpolymer complex formation of chitosan with gelatine on the release behaviour of Tramadol hydrochloride. Drug Delv. Ind. Pharm. 2007. 33: p. 7-17. (Pubitemid 46034145)
11. Keresztessy, Z.; Ber, E.; Hajdu, I.; Zhang, M.; Hartmann, J.F.; Self-assembling chitosan/poly-γ-glutamic acid nanoparticles for targeted drug delivery. Colloid. Polym. Sci. 2009. 287: p. 759-765.
12. Xiao, C.; Ionic self-assembly and characterization of a polysaccharide-based polyelectrolyte complex of maleic starch half-ester acid with chitosan. J. Appl. Polym. Sci. 2008. 112: p. 2255-2260.
13. Silva, C.L.; Ramalho A.; Pais, A.A.C.C.; Sousa, J.S.J; Films based on chitosan polyelectrolyte complexes for skin drug delivery: Development and characterization. J. Membr Sci. 2008. 320: p. 268-279.
14. Lorenzo-Lamosa, M.L.; Vila-Jato, J.L.; Alonso, M.J.; Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control Release 1998. 52: p. 109-118. (Pubitemid 28123178)
15. Yoshizawa, T.; Hong, K.J.; Kajiuchi, T.; pH and temperature-sensitive release behaviours from polyelectrolyte complex films composed of chitosan and PAOMA copolymer. Eur. J. Pharm. Biopharm. 2005. 59: p. 307-313. (Pubitemid 40127588)
16. Alves da Silva, M.; Lapa, E.; Guthrie, J.T.; Photosensitized grafting of acrylamide and hydroxyethtyl methacrylate onto cellulose. J. Appl. Polym. Sci. 1987. 34: p. 871-880. (Pubitemid 17638898)
17. Kurika, K.; Chitin and chitosan graft copolymers. In: J.C. Salamone (Ed.), Polymeric Materials Encyclopedia, CRC Press, New York 2003.
18. Pengfei, L.; Jilan, W.; Study on radiationinduced grafting of styrene onto chitin and chitosan. Radiat. Phys. Chem. 2001. 61: p. 149-153. (Pubitemid 32522429)
19. Khor, E.; Implantable applications of chitin and chitosan. Biomaterials, 2003. 24: p. 2339.
20. Carenza, M.; Recent achievements in the use of radiation polymerisation and grafting for biomedical applications. Radiat. Phys. Chem. 1992. 39: p. 485-493.
21. Montheard, J.P.; Chappard, D.; 2-hydroxyethyl methacrylate (HEMA): chemical properties and applications in biomedical fields. JMS Rev. Macromol. Chem. Phys. 1992. 32: p. 1-34.
22. Ferreira, L.M.; Andrade, M.E.; Gil, M.H.; Preparation and characterisation of polyethylene based graft copolymers. Applications in the immobilization of enzymes. Radiat. Phys. Chem. 1998. 52: p. 207-212. (Pubitemid 28305103)
23. Shantha, K.L.; Rao, K.P.; Tailor-made chitosans for drug delivery. Eur. Polym. J., 1998. 31: p. 377-382.
24. Ahn, J.S.; Chun, M.K.; Ryu, J.M.; Release of triamcinolone acetonide from mucoadhesive polymer composed by chitosan and poly(acrylic acid) in vitro. Biomaterials, 2002. 23: p. 1411-1416.
25. Zhang, M,.; Gong, Y.D.; Zhao, N.M.; Zhang, X.F.; Properties and biocompatibility of chitosan films modified by blendingwith PEG. Biomaterials, 2002. 23: p. 2641-2648. (Pubitemid 34465727)
26. Gupta, K.C.; pH dependent hydrolysis and drug release behavior of chitosan / poly(ethylene glycol) polymer network microspheres. J. Mater Sci.: Mater in Med. 2001b. 12: p. 753-759. (Pubitemid 32996114)
27. Gupta, K.C.; Studies in interpenetrating polymer network beads of chitosan poly(ethylene glycol) for controlled release of drug. J. Appl. Polym. Sci. 2001a. 80: p. 639-649. (Pubitemid 32248523)
28. Kashyab, N.; Sharma, G.;, Bhardwaj, V.; Ramarao, P.; Ravi Kumar, M.N.V.; Design and evaluation of biodegradable biosensitive in situ gelling system for pulsatile delivery of insulin. Biomaterials, 2007. 28: p. 2051-5060.
29. Peniche, C.; Davidenko, N.; Sastre, R.; Gallardo, A.; San Roman, J.; Self-curing membranes of chitosan / PAA IPNs obtained by radical polymerization preparation characterization and interpolymer complexation. Biomaterials, 1999. 20: p. 1869-1878. (Pubitemid 29421703)
30. Borzacchielo, A.; Netti, P.A.; Nicolais, L.; Chitosan-based hydrogels: synthesis and characterization. J. Mater. Sci.: Mater in Med. 2001. 12: p. 861-864. (Pubitemid 34062102)
31. Agnihotri, S.A.; Novel interpenetrating network chitosan-poly (ethylene oxide-g-acrylamide) hydrogel microspheresfor the controlled release of Capecitabine. Int. J. Pharm. 2006. 324: p. 103-115. (Pubitemid 44528908)
32. Schellekens, R.; A drawing behaviour of poly vinyl alcohol fibres. J. Appl. Polym. Sci. 1991. 43: p. 2311-2315.
33. Risbud, M.V.; Bhat, S.V.; Bhonde, R.R.; pH-sensitive freeze dried chitosan poly vinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J. Control Release 2000. 68: p. 23-30. (Pubitemid 30407059)
34. Marsano, E.; Vicini, S.; Compagnino, L.; Sionkowski, A.; Skopinska, J.; Wisniewski M.; Stimuli responsive gels based on interpenetrating networks of chitosan and poly-(vinylpyrrolidone). Polymer, 2005. 46: p. 1595-1600. (Pubitemid 40170123)
35. Chang, J.; Application of Nanoparticles in controlled release of anticancer drugs : Preparation and evaluation in vitro of methotrezate-o - carboxymethylate chitosan nanoparticles. Chinese J. Biomed. Eng. 1996. 15: p. 102-106.
36. Jeong, Y.I.; Kim, S.H.; Nah, J.W.; Lee, Y.M.; Chlonazepam release from core shell type nanoparticles in vitro. J. Control Release 1998. 51: p. 169-178.
37. Dunn, E.J.; Sun, D.; Goosen, M.F.A.; Synthesis of N-(aminoalkyl) chitosan for microcapsules. J. Appl. Polym. Sci., 1993. 50: p. 353-365.
38. Onishi, H.; Machida, Y.; McGinity, J.W.; Preparation and in vitro evaluation of chitosan microspheres containing prednisolone : comparison of simple and conjugate microspheres. J. Drug Delv. Ind. Pharm. 2005. 312: p. 597-605. (Pubitemid 41356201)
39. Thanou, M.; Geldof, M.; Junginger, H.E.; Borchard, G.; Quaternized chitosan oligomers as novel gene delivery vector in epithelial cell lines. Biomaterials, 2002. 23: p. 153-159. (Pubitemid 33041349)
40. Chen, F.; Huang, Y.; Evaluation and modifications of N-trimethyl chitosan chloride nanoparticles as protein carriers. Int. J. Pharm., 2007. 336: p. 166-173. (Pubitemid 46551555)
41. Aiedeh, K.; Synthesis of succinate and chitosan phthalate and their evaluation as suggested matrics in orally administrated, colon specificdrug delivery systems. Archiv. Der. Pharmazie 1999. 332.
42. Lee, K.Y.; Kim, Y.H.; Jo, W.H.; Jeong , S.Y.; Preparation of chitosan self aggregates as a gene delivery system. J. Control Release, 1998. 51: p. 213-220. (Pubitemid 28252873)
43. Park, J.H.; Son, Y.J.; Preparation and characterization of self - assembled nanoparticles based on glycol chitosan bearing adriamycin. Colloid. Polym. Sci., 2006. 284: p. 763-770. (Pubitemid 43904810)
44. Giunchedi, M.; Establishment of sink conditions in dissolution rate determinations : Theoretical considerations and application to disintegrating dosage forms. J. Pharm. Sci., 1967. 56: p. 1238-1242.
45. Chen, X.G.; Park, H.J.; O/W emulsification for the self aggregration and nanoparticles formation of lionelic acids modified chitosan in the aqueous system. J. Agric. Food Chem., 2003. 51: p. 3135-3139.
46. Zhang, C.; Ding, Y.; Cheng, Y.; Shen, J.; Synthesis, characterization and microsphere formation of galactosylated chitosan. J. of Appl. Polym. Sci., 2004. 91: p. 659-665. (Pubitemid 38014265)
47. Jayakumar, R; Mano, J.F.; Synthesis and characterization of pH sensitive thiol - containing chitosan beads for controlled drug delivery applications. Drug Deliv., 2007. 14: p. 9-17. (Pubitemid 44764454)
48. Saboktakin, M.R.; Tabatabaie, R.; Maharramov, A.; Ramazanov, M.A;. Synthesis and characterization of superparamagnetic chitosan-dextran sulfate hydrogels as nano carriers for colonspecific drug delivery. Carbohydr. Polymers, 2010. 81: p. 372-376.
49. Saboktakin, M.R.; Tabatabaie, R.; Maharramov, A.; Ramazanov, M.A.; Synthesis and characterization of chitosan hydrogels containing 5-Aminosalicylic acid nanopendents for colon: specific drug delivery. J. Pharm. Sci. 2010. 99: p. 4955-4961.
50. Saboktakin, M.R.; Tabatabaie, R.; Maharramov, A.; Ramazanov, M.A.; Synthesis and in vitro studies of biodegradable thiolated chitosan hydrogels for breast cancer therapy. Int. J. Bio. Macromol., 2011, 48 : p. 747-752.
51. Saboktakin, M.R.; Tabatabaie, R.; Maharramov, A.; Ramazanov, M.A.; Development and in vitro evaluation of thiolated chitosan - polymethacrylic acid nanoparticles as a local mucoadhesive system. Int. J. Bio. Macromol., 2011, 48 : p. 403-407.
52. Saboktakin, M.R.; Tabatabaie, R.; Maharramov, A.; Ramazanov, M.A.; Synthesis and in vitro evaluation of carboxymethyl starchchitosan nanoparticles as drug delivery system to the colon. Int. J. Bio. Macromol., 2011, 48, p. 381-385.
53. Thanou, M.; Kydonieus, A.; Elson, C.J.; N-sulfonato-N, Ocarboxymethylchitosan: A novel polymeric absorption enhancer for the oral delivery of macromolecules. J. Control. Release, 2007. 117: p. 171-178. (Pubitemid 46161881)
54. Bigucci, F.; Cerchiara, T.; et al. Chitosan/pectin polyelectrolyte complexes: Selection of suitable preparative conditions for colonspecific delivery of vancomycin. Eur. J. Pharm. Sci., 2008. 35: p. 435-441.
55. Kumar, S.G, Aminabhavi, T.M.; Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent. J. Microencaps., 2002. 19: p. 173-180. (Pubitemid 34100610)
56. Rokhade, A.P.; Aminabhavi, T.M.; Synthesis and characterization of semiinterpenetrating polymer network microspheres of acrylamide grafted dextran and chitosan for controlled release of acyclovir. Carbohydr. Polymer, 2007. 67: p. 605-613. (Pubitemid 46097092)
57. Agnihotri, S.A.; Int. J. Pharm. 2006. 325: p. 136-142.
58. Kaur G.;, Jain S.; Tiwary A.K.; Colon delivery of budesonide: Evaluation of chitosan-chondroitin sulphate interpolymer complex. AAPS Pharm. Sci. Tech. 2009. 11: p. 36-45.
59. Kaur, G.; Tiwary, A.K.; Chitosan-Carboxymethyl Tamarind Kernel Powder Interpolymer Complexation: Investigations for Colon Drug delivery. Sci. Pharm., 2010. 78: p. 57-78.
60. Muzzarelli, C.; Gobbi, L.; Tosi, G.; Muzzarelli, R.; Spray-drying of solutions containing chitosan together with polyuronans and characterisation of the microspheres. Carbohydr. Polymer, 2010. 57: p. 73-82.
61. Xia, W.; Liu, J.; Advance in chitosan hydrolysis by non-specific cellulases. Biores. Technol. 2008. 99: p. 6751-6762.
62. Sinha, V.R.; Bhutani, K.K.; Kumria, R.; Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int. J. Pharm., 2004. 269: p. 101-108. (Pubitemid 38032827)
63. Shantha, K.L., Bala, U., Rao, K.P.,(1995)," Tailor-made chitosans for drug delivery", Euro. Polym.. J., 31, 377-382.
64. Kim, Y.H.; Park, C.R.; Structural Characteristics of Size-Controlled Self-Aggregates of Deoxycholic Acid-Modified Chitosan and Their Application as a DNA Delivery. Carrier Bioconjug. Chem., 2001. 12: p. 932-938.
65. Macleod, G.S.; Collett, J.H.; Sharma, H.L.; Smith, A.; Selective drug delivery to the colon using pectin:chitosan:hydroxyprophyl methylcellulose film coated tablets. Int. J. Pharm. 1999. 187: p. 251-257. (Pubitemid 29443905)
66. 1H NMR spectroscopy of chitosan and N-trimethyl chloride derivatives. Int. J. Bio. Macromol. 1986. 8: p. 105-110.
67. Aiedeh, K.; Synthesis of iron-cross-linked chitosan succinate and iron-cross-linked hydroxamated chitosan succinate and their invitro evaluation as potential matrix materials for oral theophylline sustained-release beads. Eur. J. Pharm. Sci. 2001. 13: p. 159-168. (Pubitemid 32288785)
68. Nishioka, Y.; Miyazaki, M.; Release characteristics of cisplatin chitosan mictospheres and effect of containing chitin. Chem. Pharm. Bull., 1990. 38: p. 2871-2873. (Pubitemid 20386072)
69. Jameela, S.R.; Glutaraldehyde crosslinked chitosan microspher as a long acting biodegradable drug delivery vehicle: Study on the in vitro release of mitoxantrone and invivo degradation of microspheres in rat muscle. Biomaterials, 1995. 16: p. 769-775.
70. Vander, S.M.; verhoef, J.C.; Kotze, J.F.; Junginger, H.E.; NTrimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery: Development and characterization of minitab and granules formulations. Eur. J. Pharma. Biopharm., 2004. 7: p. 85-91. (Pubitemid 38058806)
71. Zerrouk, N.; Mennini, N.; Maestrelli, F.; Mura, C.P.; "Comparison of the effect of chitosan and polyvinylpyrrolidone on properties and analgesic effect of naproxen" Eur. J .of Pharm. and Biopharm., 2004; 57(1); 93-99. (Pubitemid 38058807)
72. Sevgi, F.; Kaynarsoy, B.; Turunc, E.; Guner, i T.; Yalcin, A.; AAPS Pharm. Sci. Tech. 2009. 10: p. 104-112.
73. Sankalia, M.G.; Sankalia, J.M.; Sutariy, V.B.; Eur. J. Pharm. Biopharm., 2007. 65: p. 215-232.
74. Thanou, M.; Junginger, H.; Adv. Drug Delv. Rev., 2001. 52: p. 117-126.
75. Murata, Y.; Miyamoto, E.; Kawashima, S.; Eur. J. Pharm. Biopharm., 1999. 48: p. 49-52.
76. Lillard, J.W.; Palaniappan, R.; Pace-a microspheres for delivery of antigens. 2003.
77. Perugini, P.; Pavanetto, F.; Conti, B.; Scalia, S.; Baruffini, A.; Int. J. Pharm., 2000. 196: p. 51-61.
78. Peppas, N.A.; Bures, P.; Ichikawa, H.; Hydrogels in pharmaceutical formulations. Eur. J. Pharm. and Biopharm., 2000. 50: p. 27-46. (Pubitemid 30326687)
79. Kurika, K.; Chitin and chitosan graft copolymers. In: J.C. Salamone (Ed.), Polymeric Materials Encyclopedia, CRC Press, New York 2003.
80. Hejazi, R; Chitosan-based gastrointestinal delivery systems. J. Control Release 2003. 89: p. 151-165. (Pubitemid 36507012)
81. Devi, D.A.; Sridhar, S.; Aminabhavi, T.M.; Pervaporation separation of isopropanol/water mixtures through crosslinked chitosan membranes. J. Membr. Sci. 2005; 262: 91-99.,
82. Pervaporation separation of isopropanol/water mixtures through crosslinked chitosan membranes. J. Membr. Sci., 2005. 262: p. 91-99.
83. Mi, F.L.; Shyu, S.S.; Su, C.C.; Peng, C.K.; Synthesis and characterization of biodegradable TPP/genipin cross-linked chitosan gel beads. Polymer, 2003. 44: p. 6521-6530.
84. Neto, C.G.T.; Fonseca, J.L.C.; Pereira, M.R.; Permeability studies in chitosan membranes. Effects of crosslinking and poly(ethylene oxide) addition. Carbohydr. Research 2005; 340: 2630-2636, (Pubitemid 41606763)
85. Permeability studies in chitosan membranes. Effects of crosslinking and poly(ethylene oxide) addition. Carbohydr. Research, 2005. 340: p. 2630-2636.
86. Ngah, W.S.W.; Kamari, A.; Adsorption behaviour of Fe(II) and Fe(III) ions in aqueous solution on chitosan and cross-linked chitosan beads. Biores. Technol., 2005. 96: p. 443-450. (Pubitemid 39445973)
87. Monteiro, O.A.C.; Some studies of crosslinking chitosanglutaraldehyde interaction in a homogeneous system. Int. J. Bio. Macromol., 1999. 26: p. 119-128. (Pubitemid 29428241)
88. Gupta, K.; Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman. Carbohydr. Research, 2007. 342: p. 2244-2252. (Pubitemid 47313401)
89. Jayakumar, R.; Mano, J.F.; Synthesis of N-Carboxymethyl Chitosan Beads for Controlled Drug Delivery Applications. Mat. Sci. Forum., 2006. 516: p. 1051-1019.
90. Sharma, C.P.; Mannemcherril, R.R. 2007.
91. Sharma, C.P.; Mannemcherril, R.R. 2007.
92. Pai, C.M.; Min, M.H.; Hwang, J.S.; Cho, K.M.; 2007.
93. Kydonieus, A.; Elson, C., Thanou, M. 2007.
94. Kydonieus, A.; Elson, C., Thanou, M. 2008.
95. Maculotti, K, G.I.; Perugini, P.; Imam, M.; Bernkop-Schnurch A.; Pavanetto F., Preparation and in vitro evaluation of thiolated chitosan microparticles. J. Microencaps 2005. 22: p. 459-470. (Pubitemid 43123885)
96. Bhattarai, N.; Chou, S.; Zhang, M.; Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery. Int. J. Nanomed., 2006, 1, p. 181-187.
97. El-Kamel, A.H.; Alsarra, I.A.; Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases. AAPS Pharm. Sci. Tech. 2007. 8: p. 1-8.
98. Andreas, B.S.; Guggi D.; Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/ GSH systems. J. Control Release 2003. 93: p. 95-103. (Pubitemid 37421352)
99. Guggi, D.; Andreas, B.S.; Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin. J. Control Release, 2003. 92: p. 125-135. (Pubitemid 37130127)
100. Guggi, D.; In vitro evaluation of polymeric excipients protecting calcitonin against degradation by intestinal serine proteases. Int. J. Pharm., 2003. 252: p. 187-196. (Pubitemid 36126627)
101. Andreas, B.S.; Synthesis and in vitro evaluation of chitosan-EDTA- protease-inhibitor conjugates which might be useful in oral delivery of peptides and proteins. Pharm. Res., 1998. 15: p. 263-269.
102. Guggi, D.; Bernkop-Schnurch, A.; Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin. J. Control Release, 2003. 92: p. 125-135. (Pubitemid 37130127)
103. Illum, L.; Watts, P.J. 1998.
104. Watts, P.J.; Illum, L. 1999.
105. Watts, P.J.; Illum, L. 2002.
106. Watts, P.J.; Illum, L. 1996.
107. Watts, P.J.; Illum, L. 1996.
108. Watts, P.J.; Illum, L. 1998.
109. Finotelli, P.V.; Torres, M.A.M.; Rossi, A.M.; Leao, M.H.M.R.; 2008.
110. Alonso Fernández, M.J.; Remunan Lopez, C.; Cuna Vilan, M.M.; Alonso Sande, M.; Vila Jato, J.L.; 2005.
111. Alonso, M.J.; Nanomedecine for overcoming biological barriers. Biomed. Pharmaco. 2004; 58: 168-172.
112. Cuna Vilan, M.M.; Alonso Fernández, M.J.; Remunan Lopez, C.; Alonso Sande, M.; Vila Jato, J.L.; 2004.
113. Wu, J.; Wang, L.Y.; Su, Z.G.; Ma, G.A.; Thermosensitive hydrogel based on quaternized chitosan and poly (ethylene glycol) for nasal delivery system. Biomaterials, 2007. 28: p. 2220-2232. (Pubitemid 46216447)
114. Chenguang, L.; Xiguang, C.; Jin, P.H.; Preparation and characterization of self-assembled nanoparticles based on linolenic acid modified chitosan. J. Ocean. Uni. China 2007. 4: p. 234-239.
115. Lui, X.F.; Zang, D.Z.; Li, Z.; Yao, K.D.; Antibacterial action of chitosan and carboxy methylated chitosan. J. Appl. Polym. Sci. 2001. 79: p. 1394.
116. Kast, C.E.; Thiolated polymers-thimers: Development and in vitro evaluation of chitosan-thiglycolic acid conjugates. Biomaterials, 2001. 22: p. 2345-2352. (Pubitemid 32666227)
117. Roldo, M.; Caliceti, P.; Bernkop-schnurch, A.; Mucoadhesive thiolated chitosan as platform for oral controlled drug delivery: Synthesis and in vitro evaluation. Eur. J. Pharm. Biopharm., 2004. 57: p. 115-121. (Pubitemid 38058810)
118. Sakkinen, M.; Kanerva, H.; Lindevall, K.; Ahonen, A.; Marvola, M.; Scintigraphic Verification of adherence of a chitosan formulation to the human esophagus. Eur. J. Pharm. Biopharm., 2004. 57: p. 145-147. (Pubitemid 38058813)
119. Watts, P.J.; Pharmaceutical compositions of chitosan with type-A gelatin. 2002.
120. Kotze, A.F.; Verhoef, J.C.; Junginger, H.E.; Proc. Int. J. Control Rel. Bioact. Mat., 1998b. 25: p. 479-480.
121. Kumar, V.; Kaur, G.; Investigations on chitosan-carboxymethyl guar gum complexes interpolymer complexes for colon delivery of fluticasone. Int. J. Drug. Delv., 2010. 2: p. 242-250.
122. El-Kamel, A.H.; Alsarra, I.A.; Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases. AAPS Pharm. Sci. Tech. 2007. 8: p. 1-8.
123. Sandri, J. ; Ferrari, F.; Bonferoni, M.C.; Muzzarelli, C.; Caramella, C.; Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. Eur. J. Pharm. Biopharm., 2004. 21: p. 351-359. (Pubitemid 38156173)
124. Berscht, P.C.; Liebendörfer, A.; Kreuter, J.; In vitro evaluation of biocompatibility of different wound dressing materials J. Mat. Sci.: Mat. Med., 2005. 6: p. 201-205.
125. Shu, X.Z.; The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. Eur. J. Pharm. Biopharm., 2002. 54: p. 235-243. (Pubitemid 34919399)
126. Ilango, R.; Mullaicharan, A.R.; Jayaka, r B.; In vitro studies on buccal strips of glibenclamide using chitosan. Indian J. Pharm. Sci., 1997; 59: 232-3.,
127. In vitro studies on buccal strips of glibenclamide using chitosan. Indian J. Pharm. Sci., 1997. 59: p. 232-233.
128. Hassan El-Kamel, A.; Alsarra, I.A.; Micromatricial Metronidazole Benzoate Film as a Local Mucoadhesive Delivery System for Treatment of Periodontal Diseases. AAPS Pharm Sci Tech 2007; 8: Article 75., Micromatricial Metronidazole Benzoate Film as a Local Mucoadhesive Delivery System for Treatment of Periodontal Diseases. AAPS Pharm. Sci. Tech., 2007. 8: p. 75.
129. Calvo, P.; Alonso, M.J.; J. Pharm. Sci. 1996. 85: p. 530-536.
130. Handjani-Vila, R.M.; Rondot, B.; Vanlerberghe, A.; Int. J. Cosmetic. Sci., 1979. 1: p. 303-314.
131. Alonso, M.J.; Nanomedecine for overcoming biological barriers. Biomed. Pharmaco. 2004; 58: 168-172.
132. Calvo, P.; Vila, J.L.; Alon, So M.J.; Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm. 1997; 153: 41-50. (Pubitemid 27283332)
133. Genta, I.; Perugini, P.; Pavaneto, F.; Spadaro, A.; Puglisi, G.; Bioadhesive microspheres for ophthalmic administration of acyclovir. J. Pharm. Pharma., 1997. 49: p. 737-742. (Pubitemid 27386891)
134. Combes, C.; Chenite, A.; Wang, D; Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials, 2002. 21: p. 2155-2161. (Pubitemid 30612386)
135. Chenite, A.; Chaput, C.; Wang, D.; Combes, C.; Buschmann, M.D.; Hoemann, C.D.; Leroux, J.C.; Atkinson, B.L.; Binette, F.; Selmani, A.," Novel injectable neutral solutions of chitosan form biodegradable gels in situ", Biomaterials, 2000, 21, 2155-2161. (Pubitemid 30612386)
136. Gupta, H.; Mathur, R.; Mishra, P.; Mishra, A.K.; Velpandian, T.; Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug. Deliv., 2007. 14: p. 507-515. (Pubitemid 350135850)
137. D'Angelo, J.P.; Schur, H. 1998.
138. D'Angelo, J.P.; Schur, H. 2000.
139. Tokura S.; Sakairi N.; Nishi N.; Macromol Symp, 1997. 101: p. 389.
140. D'Angelo, J.P.; Schur, H. 1997.
141. Halim, A.S.; Stone, C.A.; Devaraj, V.S.," The Hyphecan Cap: A biological fingertip dressing.", Injury.,1998; 29, 261-263. (Pubitemid 28301677)
142. Chen, X.; Liu, Z.; Park , H.; , Biomaterials, 2002. 23: p. 4609.
143. Ragnhild, J.; Varum, K.M.; Grasden, H.; Tokur, S.; Smidsrod, O.; Carbohydr. Polymer, 1998. 34: p. 131.
144. Deng, C.M.; Zhao, M.; Yang , D.; Liu, Y.; Biological properties of the chitosan-gelatin sponge wound dressing. Carbohydr. Polymer, 2007. 69: p. 583-589. (Pubitemid 46693992)
145. Wenming, X; Wei, W.; Qing, L; Preparation and antibacterial activity of a water soluble chitosan derivative. Carbohydr. Polymer, 2002. 50: p. 35-40.
146. Kotze, A.F.; De Leeuw, B.J.; De Boer, A.G.; Verhoef, J.C.; Junginge, HE.; Pharm. Res., 1997. 14: p. 1197-1202.
147. Nunthanid, J, Laungtanaanan, M, Sriamornsak, P.,"Characterization of chitosan acetate as a binder for sustained release tablets", J. Control. Rel., 2004; 99: 15-26. (Pubitemid 39165730)
148. Puttipipatkhachorn, S.; Yamamoto, G.; Drug physical state and drug polymer interaction on drug release from chitosan matrix films. J. Control Release 2001. 75: p. 143-153. (Pubitemid 32635204)
149. Nunthanid, J.; Sriamornsak, P.; Characterization of chitosan acetate as a binder for sustained release tablets. J. Control Release, 2004. 99: p. 15-26. (Pubitemid 39165730)
150. Zhu, A.P.; Yuan, Y.L.; Shen, J.; Cell adhesion behavior of chitosan surface modified by bonding 2-methacryloyloxyethyl phosphorylcholine. J. Biomat. Sci. Polym. Ed., 2002. 13: p. 501-510. (Pubitemid 34846119)
151. Zhu, A.P.; Yuan, Y.L.; Shen, J.; Preparation and blood compatibility of phosphorylcholine-bonded O-butyrylchitosan. Polymer Int. 2003. 52: p. 81-85. (Pubitemid 36242576)
152. Ge, Z.; Lim, L.Y.; Wee, A.; Khor, E.; Hydroxyapatitechitin materials as potential tissue engineered bone substitutes. Biomaterials, 2004. 25: p. 1049.
153. Bae, J.W.; Chung, H.J.; Park, H.D.; Lee, J.W.; Park, K.D;" Thermosensitive chitosan as novel injectable biomaterials"; Macromolecular Symposia; 2005; 224(1); 275-286. (Pubitemid 40866926)
154. Jia, Z.; Fengping, T.; Guoqiang, J.; Ying, L.; Fuxin, D.; Preparation of Thermosensitive Chitosan Formulations Containing 5-Fluorouracil/Poly-3- hydroxybutyrate Microparticles Used as Injectable Drug Delivery System. Chinese J. Chem. Eng, 2006. 14: p. 235-241.
155. Oyarzun-Ampuero, F.A.; Loza, M.I.; Torres, D.; Alonso, M.J.; Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int. J. Pharm. 2009. 381: p. 122-129
156. Kim, S.; Bumgardner, J.D.; Haggard, W.O.; Gaber, M.W.; Yang, Y.A.; chitosan/b-, glycerophosphate thermosensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials 2010. 31: p. 4157-4166.
157. Park, D.J.; Zhu, S.J.; Huh, J.Y.; Kim B.Y.; Lee, S.H.; Injectable bone using chitosan-alginate gel/mesenchymal stem cells/BMP-2 composites. J. Cranio-Maxillofacial Sur. 2005. 33: p. 50.
158. Mitra, S.; Ghosh, P.C.; Maitra, A.N.; Tumor targeted delivery of encapsulated dextran doxorubicin conjugate using chitosan nanopoarticles as carriers. J. Control Release, 2001. 74: p. 317-323. (Pubitemid 32727639)
159. Sato, T.; Ishii, T.; Okahata, Y.;" In vitro gene delivery mediated by chitosan. Effect of pH, Serum, and molecular mass of chitosan on the transfection efficiency", Biomaterials, 2001; 22: 2075-2080. (Pubitemid 32738750)
160. Brannon-Peppas, L.; Blanchette, J.O.,(2004)," Nanoparticle and targeted systems for cancer therapy", Adv. Drug Deliver. Rev., 56, 1649.
161. Janes, K.A.; Marazuela, A.; Fabr, a A.; Alonso, M.J.; Chitosan nanoparticles as delivery systems for doxorubicin. J. Control Release, 2001. 73: p. 244-267.
162. Wang, G; Ho H.; Wang, S.; Sheu, M.; Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice. Int. J. Pharm, 2006. 319: p. 71-81. (Pubitemid 44051805)
163. Chan, P.; Chung, J.E.; Yang, Y.; Synthesis and characterization of chitosan-gpoly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials, 2007. 28: p. 540-549. (Pubitemid 44602231)
164. Xiangvan, g X.; Ling, L.; Jianping, Z.; Shiyue, L.; Jie, Y.; Jinsheng, R.; "Preparation and characterization of N-succinyl-N-octhyl chitosan micelles as doxorubicin carriers for effective anti activity"; Colloids Surf. B. Biointerfaces; 2007; 55(2); 222-8. (Pubitemid 46274249)
165. Zhang, C.; Yu, L.L.; Ping, Q.; Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives. Colloids Surface B: Biointer, 2007. 55: p. 192-199. (Pubitemid 46274240)
166. Yang, Z.; Liu, J.; Shi, W.; Synthesis of amphiphilic poly(etheramide) dendrimer endcapped with poly(ethylene glycol) grafts and its solubilization to salicylic acid. Colloids Surface B: Biointer, 2007. 55: p. 229-234. (Pubitemid 46274252)
167. Son, Y.J.; Cho, Y.W.; Biodistribution and anti-tumor efficacy of doxorubicin loaded glycolchitosan nanoaggregates by EPR effect. J. Control Release, 2003. 91: p. 135-145. (Pubitemid 37288884)
168. Luo, H.; Chen, X.; Antitumor effect of N-succinylchitosan nanoparticles on K562 cells. Biomed. Pharmacother. 2009; DOI: 10.1016/j.biopha.2009.09.002.,
169. Antitumor effect of Nsuccinylchitosan nanoparticles on K562 cells. Biomed. Pharmacother. Biomed. Pharmacother, 2009. DOI: 10.1016/j.biopha.2009.09. 002.
170. Kato, Y.; Machida, Y.; Biological characterization of lactosaminated N-succinyl chitosan as a liver specific drug carrier in mice. J. Control Release, 2001. 70: p. 295-307. (Pubitemid 32155453)
171. Park, K.; Park, Y.H.; Galactosylated chitosan -graft-poly(ethelene glycol) as hypatocyte targating DNA carrier. J. Control Release, 2001. 76: p. 349-362.
172. Gao, S.; Chen, J.; Xu, X.; Ding, Z.; Yang, Y.H.; Hua, Z.; Zhang, J.;" Galactosylated low molecular weight chitosan as DNA carrier for Hepatocyte-targating", Int. J. Pharm. 2003; 255: 57-68. (Pubitemid 36369591)
173. Thanou, M.; Geldof, M.; Junginger, H.E.; Borchard, G.; Quaternized chitosan oligomers as novel gene delivery vector in epithelial cell lines. Biomaterials, 2002. 23: p. 153-159. (Pubitemid 33041349)
174. Liu, W.G.; Liu, Q.G.; Formation of a DNA/N-dodecylated chitosan complex and salt induced gene delivery. J. Appl. Polym. Sci. 2001; 82 (14): 3391-3395., (Pubitemid 33046363)
175. Formation of a DNA/N-dodecylated chitosan complex and salt induced gene delivery. J. Appl. Polym. Sci., 2001. 82: p. 3391-3395.
176. Sonaje, K.; Juang, J.H.; Wey, S.P.; Chen, C.T.; Sung, H.W.; In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials, 2009. 30: p. 2329-2339.
177. Thanou, M.; Geldof, M;., Junginger, H.E.; Borchard, G.; Quaternized chitosan oligomers as novel gene delivery vector in epithelial cell lines. Biomaterials, 2002. 23: p. 153-159. (Pubitemid 33041349)
178. Je, J.Y.; Kim, S.K.; Cytotoxic activities of water-soluble chitosan derivatives with different degree of deacetylation. J. Bioorg. Med. Chem. Lett., 2006. 16: p. 2122-2126.
179. Brannon-Peppas, L.; Nanoparticle and targeted systems for cancer therapy. Adv. Drug Delv. Rev., 2004. 56: p. 1649.